368 related articles for article (PubMed ID: 27500794)
1. Current perspective on actinic keratosis: a review.
Siegel JA; Korgavkar K; Weinstock MA
Br J Dermatol; 2017 Aug; 177(2):350-358. PubMed ID: 27500794
[TBL] [Abstract][Full Text] [Related]
2. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
Filosa A; Filosa G
G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
[TBL] [Abstract][Full Text] [Related]
3. Addressing the Challenges of Treating Actinic Keratosis.
Kircik LH
J Drugs Dermatol; 2019 May; 18(5):s160. PubMed ID: 31141861
[TBL] [Abstract][Full Text] [Related]
4. Contemporary management of actinic keratosis.
Navarrete-Dechent C; Marghoob AA; Marchetti MA
J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
[TBL] [Abstract][Full Text] [Related]
5. Validation of a diagnostic algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma by means of high-definition optical coherence tomography.
Marneffe A; Suppa M; Miyamoto M; Del Marmol V; Boone M
Exp Dermatol; 2016 Sep; 25(9):684-7. PubMed ID: 27095632
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of actinic keratosis.
Berman B; Amini S; Valins W; Block S
Expert Opin Pharmacother; 2009 Dec; 10(18):3015-31. PubMed ID: 19925043
[TBL] [Abstract][Full Text] [Related]
8. [Actinic Keratosis].
Dejaco D; Hauser U; Zelger B; Riechelmann H
Laryngorhinootologie; 2015 Jul; 94(7):467-79; quiz 480-1. PubMed ID: 26125293
[TBL] [Abstract][Full Text] [Related]
9. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
10. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
[TBL] [Abstract][Full Text] [Related]
11. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
Beatson M; Siegel JA; Chren MM; Weinstock MA
Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
[TBL] [Abstract][Full Text] [Related]
12. Current management of actinic keratoses.
Shoimer I; Rosen N; Muhn C
Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
[TBL] [Abstract][Full Text] [Related]
13. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
15. Actinic keratosis - review for clinical practice.
de Oliveira ECV; da Motta VRV; Pantoja PC; Ilha CSO; Magalhães RF; Galadari H; Leonardi GR
Int J Dermatol; 2019 Apr; 58(4):400-407. PubMed ID: 30070357
[TBL] [Abstract][Full Text] [Related]
16. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of actinic keratoses.
Green AC
Curr Probl Dermatol; 2015; 46():1-7. PubMed ID: 25561199
[TBL] [Abstract][Full Text] [Related]
18. P53 staining index and zonal staining patterns in actinic keratoses.
Javor S; Gasparini G; Biatta CM; Cozzani E; Cabiddu F; Ravetti JL; Vellone VG; Parodi A
Arch Dermatol Res; 2021 May; 313(4):275-279. PubMed ID: 32642809
[TBL] [Abstract][Full Text] [Related]
19. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
20. Variation in the Cost of Managing Actinic Keratosis.
Kirby JS; Gregory T; Liu G; Leslie DL; Miller JJ
JAMA Dermatol; 2017 Apr; 153(4):264-269. PubMed ID: 28249074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
